Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

Van Allen Eliezer M.; Garraway Levi A.; Rosenberg Jonathan E.

首页> 外文期刊>European urology >Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

【24h】

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

机译：Re：Floris H. Groenendijk，Jeroen de Jong，Elisabeth E. Fransen Van de Putte，等。 ERBB2突变表征了肌肉侵入性膀胱癌的亚组，具有对Neoadjuvant化疗的优异反应。 EUR UROL。在新闻。 http://dx.doi.org/10.1016/j.eururo.2015.01.014

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2015年第2期|共2页
作者
Van Allen Eliezer M.; Garraway Levi A.; Rosenberg Jonathan E.;
展开▼
作者单位

Dana Farber Canc Inst Boston MA 02115 USA;

Dana Farber Canc Inst Boston MA 02115 USA;

Mem Sloan Kettering Canc Ctr New York NY 10065 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Reply to Eliezer M. Van Allen, Levi A. Garraway and Jonathan E. Rosenberg's Letter to the Editor re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014 [J] . Groenendijk Floris H., van de Putte Elisabeth E. Fransen, van Rhijn Bas W. G., European urology . 2015,第2期

机译：回复Eliezer M. Van Allen，Levi A. Garraway和Jonathan E. Rosenberg致编辑的信，关于：Floris H. Groenendijk，Jeroen de Jong，Elisabeth E. Fransen van de Putte等。 ERBB2突变表征了对新辅助化学疗法有出色反应的肌肉浸润性膀胱癌亚组。 Eur Urol。在新闻。 http://dx.doi.org/10.1016/j.eururo.2015.01.014
2. Re: Giorgio Gandaglia, Alberto Briganti, Noel Clarke, et al. Adjuvant and Salvage Radiotherapy after Radical Prostatectomy in Prostate Cancer Patients. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2017.01.039 Modern Considerations for an "Old Picture" [J] . Alongi Filippo, Aiello Dario, Mazzola Rosario, European urology . 2017,第2期

机译：Re：Giorgio Gandaglia，Alberto Briganti，Noel Clarke等。前列腺癌患者自由基前列腺切除术后的佐剂和救赎放疗。 EUR UROL。在新闻。 http://dx.doi.org/10.1016/j.eururo.2017.01.039一个“旧照片”的现代考虑因素
3. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy [J] . Groenendijk Floris H., de Jong Jeroen, van de Putte Elisabeth E. Fransen, European urology . 2016,第3期

机译：ERBB2突变表征了对新辅助化学疗法有出色反应的肌肉浸润性膀胱癌亚组。
4. Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy [O] . Zhao Yang, Ruiyun Zhang, Yunxia Ge, 2018

机译：体细胞FGFR3突变区分对新辅助化学疗法有反应的肌肉浸润性膀胱癌亚组。
5. Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy [O] . Zhao Yang, Ruiyun Zhang, Yunxia Ge, 2018

机译：Somatic FGFR3突变将肌肉侵入性膀胱癌的亚组区分开回应Neoadjuvant化疗

Re: Floris H. Groenendijk, Jeroen de Jong, Elisabeth E. Fransen van de Putte, et al. ERBB2 Mutations Characterize a Subgroup of Muscle-invasive Bladder Cancers with Excellent Response to Neoadjuvant Chemotherapy. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.01.014

著录项

相似文献

相关主题

期刊订阅